Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)

China flag China · Delayed Price · Currency is CNY
4.310
+0.140 (3.36%)
Jul 3, 2026, 3:04 PM CST
Market Cap4.69B -7.6%
Revenue (ttm)2.37B -2.8%
Net Income-270.08M
EPS-0.25
Shares Out 1.09B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume31,027,570
Open3.900
Previous Close4.170
Day's Range3.900 - 4.370
52-Week Range3.700 - 6.740
Beta0.37
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:002793

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, production, and sales of pharmaceutical products in China. The company provides anti-infective active pharmaceutical ingredients(APIs), antiviral APIs, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was forme... [Read more]

Sector Healthcare
Founded 1998
Employees 2,962
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002793
Full Company Profile

Financial Performance

In 2025, SHE:002793's revenue was 2.27 billion, a decrease of -14.12% compared to the previous year's 2.65 billion. Losses were -288.58 million, -70.11% less than in 2024.

Financial Statements